• 2022
  Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F, , , Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H, , Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
• 2022
  C. Planchais, I. Fernandez, T. Bruel, G. Dias de Melo, M. Prot, M. Beretta, P. Guardado-Calvo, J. Dufloo, L. M. Molinos-Albert, M. Backovic, J. Chiaravalli, E. Giraud, B. Versin, L. Conquet, L. Grzelak, D. Planas, I. Staropoli, Florence Guivel-Benhassine, M. Boullé, M. Cervantes-Gonzaalez, French COVID Cohort Study Group, CORSER Study Group, Marie-Noëlle Ungeheuer, P. Charneau, S. Van der Werf, F. Agou, J. D. Dimitrov, E. Simon-Lorière, H. Bourhy, X. Montagutelli, F. Rey, O. Schwartz, H. Mouquet , Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2, J Exp Med . 2022 Jul 4;219(7):e20220638. doi: 10.1084/jem.20220638. Epub 2022 Jun 15. .
• 2022
  Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, Holden K, Zimmer G, Simon-Lorière E, Bruel T, Schwartz O, van der Werf S, Jouvenet N, Nisole S, Vignuzzi M, Roesch F, , Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen., Nat Commun 2022 May; 13(1): 2442.
• 2022
  Temmam S, Vongphayloth K, Salazar EB, Munier S, Bonomi M, Regnault B, Douangboubpha B, Karami Y, Chrétien D, Sanamxay D, Xayaphet V, Paphaphanh P, Lacoste V, Somlor S, Lakeomany K, Phommavanh N, Pérot P, Dehan O, Amara F, Donati F, Bigot T, Nilges M, Rey FA, van der Werf S, Brey PT, Eloit M, , Bat coronaviruses related to SARS-CoV-2 and infectious for human cells., Nature 2022 604, 330–336.
• 2021
  Di Gioacchino A, Legendre R, Rahou Y, Najburg V, Charneau P, Greenbaum BD, Tangy F, van der Werf S, Cocco S, Komarova AV, , sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs., RNA 2021 Dec; (): .
• 2021
  Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, Loan Bourdon, Christophe Malabat, Thomas Vallet, Marco Vignuzzi, Sylvie van der Werf, Sylvie Behillil, Flora Donati, Nathalie Sauvonnet, Giulia Nigro, Maryline Bourgine, Nolwenn Jouvenet, and Germano Cecere, A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection, EMBO Reports (2021)e54341.
• 2021
  Singh M, Chazal M, Quarato P, Bourdon L, Malabat C, Vallet T, Vignuzzi M, van der Werf S, Behillil S, Donati F, Sauvonnet N, Nigro G, Bourgine M, Jouvenet N, Cecere G, , A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection., EMBO Rep 2021 Dec; (): e54341.
• 2021
  Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A, , Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2021 Sep; 8(): 100171.
• 2021
  Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M, , Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
• 2021
  Le Vu S, Jones G, Anna F, Rose T, Richard JB, Bernard-Stoecklin S, Goyard S, Demeret C, Helynck O, Escriou N, Gransagne M, Petres S, Robin C, Monnet V, Perrin de Facci L, Ungeheuer MN, Léon L, Guillois Y, Filleul L, Charneau P, Lévy-Bruhl D, van der Werf S, Noel H, , Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance., Nat Commun 2021 05; 12(1): 3025.
• 2021
  Pierre Garneret,Etienne Coz, Elian Martin, Jean-Claude Manuguerra, Elodie Brient-Litzler, Vincent Enouf, Daniel Felipe González Obando, Jean-Christophe Olivo-Marin, Fabrice Monti, Sylvie van der Werf, Jessica Vanhomwegen, Patrick Tabeling, Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification, PLOS ONE, 16(1), e0243712 - January 2021.
• 2020
  Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, Casartelli N, Mouquet H, Bruel T, Schwartz O, , Syncytia formation by SARS-CoV-2-infected cells., EMBO J 2020 12; 39(23): e106267.
• 2020
  Declercq M, Biquand E, Karim M, Pietrosemoli N, Jacob Y, Demeret C, Barbezange C, van der Werf S, , Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription., Nucleic Acids Res. 2020 Sep; (): .
• 2020
  Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S, , A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations., Sci Transl Med 2020 09; 12(559): .
• 2020
  Pierre Garneret, Etienne Coz, Elian Martin, Jean-Claude Manuguerra, Elodie Brient-Litzler, Vincent Enouf, Daniel Felipe Gonzalez Obando, Jean-Christophe Olivo-Marin, Fabrice Monti, Sylvie Van der Werf, Jessica Vanhomwegen, Patrick Jean Tabeling, Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification., medRxiv 2020.08.01.20166538.
• 2020
  Gámbaro F, Behillil S, Baidaliuk A, Donati F, Albert M, Alexandru A, Vanpeene M, Bizard M, Brisebarre A, Barbet M, Derrar F, van der Werf S, Enouf V, Simon-Loriere E, , Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020., Euro Surveill. 2020 07; 25(26): .
• 2017
  Domenech de Cellès M, Arduin H, Varon E, Souty C, Boëlle PY, Lévy-Bruhl D, van der Werf S, Soulary JC, Guillemot D, Watier L, Opatowski L, Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms, Am. J. Epidemiol. 2018 05;187(5):1029-1039.
• 2014
  Crescenzo-Chaigne B, Barbezange C, Frigard V, Poulain D, van der Werf S, Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulation, PLoS ONE 2014;9(9):e109046.
• 2013
  Crescenzo-Chaigne B, Barbezange C, van der Werf S, The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expression, PLoS ONE 2013;8(11):e81550.
• 2013
  Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM, Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility, Lancet Infect Dis 2014 Jan;14(1):50-56.
• 2013
  Desdouits M, Munier S, Prevost MC, Jeannin P, Butler-Browne G, Ozden S, Gessain A, Van Der Werf S, Naffakh N, Ceccaldi PE, Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses, PLoS ONE 2013;8(11):e79628.
• 2013
  Opatowski L, Varon E, Dupont C, Temime L, van der Werf S, Gutmann L, Boëlle PY, Watier L, Guillemot D, Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models, Proc. Biol. Sci. 2013 Aug;280(1764):20130519.
• 2012
  Heraud JM, Njouom R, Rousset D, Kadjo H, Caro V, Ndiaye MN, Victoir K, Collard JM, Orelle A, Yekwa EL, Ekaza E, Razanajatovo NH, Adamou L, Biscornet L, Enouf V, van der Werf S, Diop OM, Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network, J. Infect. Dis. 2012 Dec;206 Suppl 1:S5-13.
• 2011
  Rameix-Welti MA, Munier S, Le Gal S, Cuvelier F, Agou F, Enouf V, Naffakh N, van der Werf S, Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution, Antivir. Ther. (Lond.) 2011;16(4):597-603.
• 2009
  Naffakh N, van der Werf S, April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission, Microbes Infect. 2009 Jul-Aug;11(8-9):725-8.
• 2008
  Rameix-Welti MA, Tomoiu A, Dos Santos Afonso E, van der Werf S, Naffakh N, Avian Influenza A virus polymerase association with nucleoprotein, but not polymerase assembly, is impaired in human cells during the course of infection, J. Virol. 2009 Feb;83(3):1320-31.
• 2008
  Crescenzo-Chaigne B, Barbezange C, van der Werf S, Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes, Virol. J. 2008;5:132.
• 2008
  Naffakh N, Tomoiu A, Rameix-Welti MA, van der Werf S, Host restriction of avian influenza viruses at the level of the ribonucleoproteins, Annu. Rev. Microbiol. 2008;62:403-24.
• 2007
  Crescenzo-Chaigne B, van der Werf S, Rescue of influenza C virus from recombinant DNA, J. Virol. 2007 Oct;81(20):11282-9.
• 2007
  Buchy P, Mardy S, Vong S, Toyoda T, Aubin JT, Miller M, Touch S, Sovann L, Dufourcq JB, Richner B, Tu PV, Tien NT, Lim W, Peiris JS, Van der Werf S, Influenza A/H5N1 virus infection in humans in Cambodia, J. Clin. Virol. 2007 Jul;39(3):164-8.
• 2007
  Labadie K, Dos Santos Afonso E, Rameix-Welti MA, van der Werf S, Naffakh N, Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells, Virology 2007 Jun;362(2):271-82.
• 2007
  Medeiros R, Rameix-Welti MA, Lorin V, Ribaud P, Manuguerra JC, Socie G, Scieux C, Naffakh N, van der Werf S, Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus, Antivir. Ther. (Lond.) 2007;12(4):571-6.
• 2005
  Vieira Machado A, Naffakh N, Gerbaud S, van der Werf S, Escriou N, Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5′ terminal sequence: induction of heterospecific B and T cell responses in mice, Virology 2006 Feb;345(1):73-87.
• 2005
  Massin P, Rodrigues P, Marasescu M, van der Werf S, Naffakh N, Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells, J. Virol. 2005 Nov;79(21):13811-6.
• 2005
  Dos Santos Afonso E, Escriou N, Leclercq I, van der Werf S, Naffakh N, The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment, Virology 2005 Oct;341(1):34-46.
• 2003
  Machado AV, Naffakh N, van der Werf S, Escriou N, Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter, Virology 2003 Aug;313(1):235-49.
• 2003
  Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, Antignac A, Deghmane AE, Huerre M, van der Werf S, Taha MK, , A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice., FEMS Microbiol Lett 2003 May; 222(1): 99-106.
• 2002
  Crescenzo-Chaigne B, van der Werf S, Naffakh N, Differential effect of nucleotide substitutions in the 3′ arm of the influenza A virus vRNA promoter on transcription/replication by avian and human polymerase complexes is related to the nature of PB2 amino acid 627, Virology 2002 Nov;303(2):240-52.
• 2002
  Vignuzzi M, Gerbaud S, van der Werf S, Escriou N, Expression of a membrane-anchored glycoprotein, the influenza virus hemagglutinin, by dicistronic replicons derived from the poliovirus genome, J. Virol. 2002 May;76(10):5285-90.